Enel Health®Atlas
Sign in
Enel Health®Atlas
Browse libraries

Not medical advice. The Atlas is not a substitute for a clinician who can examine you.

Antioxidant & Supplement Claims for Fertility

The MOXI trial null result and the supplement marketplace

Evidence grade 2 of 5, Thin. Read how the Atlas grades evidence.

The written rationale for this grade is still being prepared.

FDA
Dietary supplements (not FDA-approved to treat infertility)

Reference only. Not medical advice.

What can go wrong

Direct harm is usually low, but supplements are unregulated for efficacy, vary in content and purity, and can cause 'reductive stress' or interact with conditions at high doses (e.g., excess zinc, vitamin E, selenium toxicity). The bigger risk is opportunity cost and false reassurance - spending months and money on pills while a treatable cause (varicocele, anabolic steroids, obstruction) goes unaddressed.

This is something to take to a clinician. The Atlas can tell you what is known about antioxidant & supplement claims for fertility in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.

Antioxidant and 'male fertility' supplements (vitamin C/E, zinc, selenium, folate, L-carnitine, CoQ10, lycopene, ashwagandha, proprietary blends like FertilAid or Conception) are marketed to improve sperm count, motility, and DNA integrity. The rationale - reducing oxidative stress - is biologically plausible, but the best randomized evidence is unimpressive: the NIH-funded MOXI trial (2020) found no improvement in semen parameters, DNA fragmentation, or live birth, and a major Cochrane review remains low-certainty.

A popular fix with a famous negative trial behind it.

What people take it for

These are the reasons people give for taking it. They are not effects it has been shown to have.

  • Marketed for low count/motility/morphology
  • Marketed to lower DNA fragmentation
  • Self-treatment for unexplained male subfertility

How it is supposed to work

Reactive oxygen species can damage sperm membranes and DNA; antioxidants theoretically neutralize them, and several ingredients participate in spermatogenesis (zinc, selenium, folate). The plausible mechanism is why supplements proliferate - but mechanism is not outcome, and randomized trials have not translated the antioxidant rationale into improved live births.

What people get wrong

  • Often saidAntioxidant supplements boost fertility and live-birth rates

    ActuallyThe NIH-funded MOXI trial found no benefit on semen parameters, DNA fragmentation, or live birth, and Cochrane rates the overall evidence low-certainty.

  • Often said'Clinically studied' on a label means it works

    ActuallyIngredient-level or small studies do not equal proven live-birth benefit; the largest randomized trial was negative.

Who profits, and who pushes back

Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.

How we got here

Oxidative-stress theories of male infertility (the late-20th-century focus on reactive oxygen species and sperm) seeded a supplement industry. Enthusiastic small studies and meta-analyses fed optimism until the rigorously designed, NIH-funded MOXI trial reported a clear null in 2020, prompting more cautious guideline language.

  1. 1990s-2000sOxidative-stress model of male infertility popularized
  2. 2000s-2010sAntioxidant supplements proliferate on mechanistic and small-study claims
  3. 2019Cochrane review flags low-certainty evidence
  4. 2020MOXI trial reports no benefit on parameters, DNA fragmentation, or live birth

Set against the alternatives

Against MOXI's null and Cochrane's low-certainty verdict, marketing claims for specific blends are not well supported. Addressing documented deficiencies or clear oxidative pathology may help select patients, but routine supplementation for unexplained male subfertility lacks robust live-birth evidence.

What we do not know

  • Is there a subgroup (documented oxidative stress or deficiency) that genuinely benefits?
  • Why does a plausible mechanism keep failing to produce live-birth benefit in trials?
  • Can high-dose antioxidants paradoxically harm via reductive stress?

At a glance

MOXI trial
2020, NIH/RMN; antioxidant combo vs placebo in infertile men
MOXI result
no improvement in semen parameters, DNA fragmentation, or live birth
Cochrane
evidence for antioxidants graded low/very-low certainty
Common ingredients
vitamin C, E, zinc, selenium, folate, L-carnitine, CoQ10

What this entry does not yet cover

What follows is unfinished work on our side, not a finding about Antioxidant & Supplement Claims for Fertility. A short entry is not a safe entry.

  • Cost and market. We have not documented what it sells for or who sells it.
  • Supply chain. We have not mapped where it is made.
  • Who uses it. We have not documented the user groups.
  • What could change. No forward-looking summary yet.
  • Children and teenagers. We have not checked what is known about younger people.

Sources

The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.

The studies that matter

  • MOXI randomized trial (Steiner et al., Fertility & Sterility)2020

    Antioxidant formulation showed no improvement over placebo in sperm concentration, motility, morphology, DNA fragmentation, or live-birth/pregnancy rates

  • Cochrane review of antioxidants for male subfertility2019/2022 updates

    Concluded evidence for live birth and pregnancy is of low or very low certainty; firm conclusions not possible